|
|
Article: Panacea Forms Subsidiary To Focus On In Vitro Diagnostics.(Company overview)
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Washington Editor
Panacea Pharmaceuticals Inc. formed a wholly owned subsidiary to develop and commercialize in vitro diagnostics, including pharmacogenomic and pharmacoproteomic tools for cancer detection, diagnosis, prognosis, treatment selection and follow-up.
Located in Gaithersburg, Md., Panacea, a company founded in 1999, works in functional genomics and proteomics to develop therapeutics and diagnostics. In product development, the company's focus is on proteins and biochemical pathways related to cellular regulation and cell cycle abnormalities in oncology and neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.